Cargando…
联合血清肿瘤标志物建立预测厄洛替尼治疗复治非小细胞肺癌生存模型
BACKGROUND AND OBJECTIVE: Molecular targeting therapy is the direction of individualized treatment of lung cancer, scholars has been established targeted therapy prediction models which provide more guidance for clinical individual therapy. This study investigated the relationship among pulmonary su...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000447/ https://www.ncbi.nlm.nih.gov/pubmed/24854556 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.05.05 |
Ejemplares similares
-
厄洛替尼致间质性肺病4例并文献复习
Publicado: (2012) -
厄洛替尼治疗34例肺鳞癌患者的疗效观察
Publicado: (2016) -
肺癌血清肿瘤标志物meta分析
Publicado: (2010) -
厄洛替尼治疗晚期非小细胞肺癌分类及回归树分析
Publicado: (2011) -
肺癌血清肿瘤标志物的临床意义
Publicado: (2011)